CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 71 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2017. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $108 | -99.9% | 986,072 | -0.2% | 0.00% | – |
| Q3 2022 | $163,000 | -34.5% | 988,419 | 0.0% | 0.00% | – |
| Q2 2022 | $249,000 | -56.0% | 988,419 | -7.3% | 0.00% | – |
| Q1 2022 | $566,000 | -34.0% | 1,066,781 | -23.5% | 0.00% | – |
| Q4 2021 | $858,000 | -39.3% | 1,393,897 | +0.6% | 0.00% | – |
| Q3 2021 | $1,413,000 | -43.1% | 1,386,108 | +2.1% | 0.00% | – |
| Q2 2021 | $2,484,000 | -21.5% | 1,357,449 | -15.6% | 0.00% | – |
| Q1 2021 | $3,166,000 | +81.1% | 1,607,521 | +14.9% | 0.00% | – |
| Q4 2020 | $1,748,000 | -23.2% | 1,398,790 | +10.7% | 0.00% | – |
| Q3 2020 | $2,275,000 | -71.3% | 1,263,982 | +33.8% | 0.00% | -100.0% |
| Q2 2020 | $7,922,000 | +52.6% | 944,369 | -4.7% | 0.00% | +100.0% |
| Q1 2020 | $5,190,000 | -39.1% | 990,587 | -36.5% | 0.00% | 0.0% |
| Q4 2019 | $8,516,000 | +134.3% | 1,559,910 | +109.0% | 0.00% | 0.0% |
| Q3 2019 | $3,634,000 | -24.6% | 746,212 | +7.3% | 0.00% | 0.0% |
| Q2 2019 | $4,821,000 | +9.8% | 695,675 | +10.1% | 0.00% | 0.0% |
| Q1 2019 | $4,391,000 | -30.7% | 631,874 | -41.8% | 0.00% | 0.0% |
| Q4 2018 | $6,338,000 | +63.3% | 1,085,444 | +111.1% | 0.00% | 0.0% |
| Q3 2018 | $3,881,000 | +55.9% | 514,140 | +4.3% | 0.00% | 0.0% |
| Q2 2018 | $2,490,000 | -1.3% | 493,070 | +19.2% | 0.00% | 0.0% |
| Q1 2018 | $2,524,000 | -13.1% | 413,811 | +1.1% | 0.00% | 0.0% |
| Q4 2017 | $2,905,000 | +9.4% | 409,365 | +10.2% | 0.00% | 0.0% |
| Q3 2017 | $2,655,000 | +49.0% | 371,371 | +31.3% | 0.00% | 0.0% |
| Q2 2017 | $1,782,000 | +7.4% | 282,862 | +40.6% | 0.00% | 0.0% |
| Q1 2017 | $1,659,000 | +13.7% | 201,177 | +16.5% | 0.00% | 0.0% |
| Q4 2016 | $1,459,000 | +24.8% | 172,685 | +0.3% | 0.00% | 0.0% |
| Q3 2016 | $1,169,000 | +172.5% | 172,201 | +19.9% | 0.00% | – |
| Q2 2016 | $429,000 | +160.0% | 143,582 | +57.4% | 0.00% | – |
| Q1 2016 | $165,000 | +10.0% | 91,235 | 0.0% | 0.00% | – |
| Q4 2015 | $150,000 | +4.9% | 91,235 | 0.0% | 0.00% | – |
| Q3 2015 | $143,000 | – | 91,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $42,335,000 | 24.44% |
| MANGROVE PARTNERS IM, LLC | 552,200 | $4,633,000 | 1.13% |
| ETF MANAGERS GROUP, LLC | 3,707,912 | $31,109,000 | 1.10% |
| Ikarian Capital, LLC | 1,350,000 | $11,327,000 | 0.90% |
| GENERAL AMERICAN INVESTORS CO INC | 712,400 | $5,977,000 | 0.76% |
| AdvisorShares Investments LLC | 189,814 | $1,593,000 | 0.68% |
| Ikarian Capital, LLC | 1,000,000 | $8,390,000 | 0.67% |
| Granite Point Capital Management, L.P. | 1,123,600 | $9,427,000 | 0.48% |
| Carmignac Gestion | 3,773,440 | $31,659,000 | 0.44% |
| Omnia Family Wealth, LLC | 32,356 | $271,467,000 | 0.27% |